Skip to main content
Equibles
GALT logo

GALT · Galectin Therapeutics Inc

Track GALT — free

Use GALT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.61 +0.26 (+5.98%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”
View the 10-Q filed Aug 14, 2026
Market Cap
$464.92M
Shares
100.85M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

No Exempt Offerings

No Form D exempt-offering notices are available for this stock yet.

Key facts CIK 1133416 CUSIP 363225202 13F (30d) 67 filings 65 filers Visit website Investor relations